Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting-Reference-Cited by-同舟云学术

Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

Published:2002-12-15 Issue:12 Volume:110 Page:1813-1822
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Dutoit Valérie,Taub Robert N.,Papadopoulos Kyriakos P.,Talbot Susan,Keohan Mary-Louise,Brehm Michelle,Gnjatic Sacha,Harris Paul E.,Bisikirska Brygida,Guillaume Philippe,Cerottini Jean-Charles,Hesdorffer Charles S.,Old Lloyd J.,Valmori Danila

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference34 articles.

1. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

2. Immunity to Oncogenic Proteins

3. Human papillomarivus vaccines for cervical cancer

4. A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy;Clinical and Translational Medicine;2024-09

2. Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study;Vaccines;2023-03-13

3. PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses;Frontiers in Immunology;2021-02-25

4. Sensitive and Quantitative Detection of MHC-I Displayed Neoepitopes Using a Semiautomated Workflow and TOMAHAQ Mass Spectrometry;Molecular & Cellular Proteomics;2021

5. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application;Cancer Letters;2020-06